Bio-Tek
Instruments, Inc.,
manufacturer of Bio-Analytical Instrumentation and
Biomedical products, announced today that the U.S.
Food and Drug Administration (FDA) cleared the
ABS2000 for marketing in the United States.
Manufactured by Bio-Tek Instruments exclusively for
Immucor, Inc., located in Norcross, GA, the ABS2000
is the first fully automated, walk-away instrument
for the hospital blood bank transfusion laboratory.
manufacturer of Bio-Analytical Instrumentation and
Biomedical products, announced today that the U.S.
Food and Drug Administration (FDA) cleared the
ABS2000 for marketing in the United States.
Manufactured by Bio-Tek Instruments exclusively for Immucor, Inc., located in Norcross, GA, the ABS2000
is the first fully automated, walk-away instrument
for the hospital blood bank transfusion laboratory.
When asked about the clearance,
Adam L. Alpert, Vice President, Systems, stated that
"In combination with Immucor’s quality
blood banking reagents, the ABS2000 is the only
competitive licensed automated instrument able to
provide significant labor reduction while increasing
productivity and patient safety". Commenting
further, Mr. Alpert said "There are more than
2500 facilities in the US able to benefit from the
quality and productivity improvements provided by the
ABS2000. Placements of the ABS2000 in Canada and
Europe already yield over 20,000 blood type test
results every month."
Founded in 1969, Bio-Tek
Instruments employs 220 people with manufacturing in
Winooski, Vermont and distribution throughout the
world.
For further information, contact Mr.
Adam Alpert, Bio-Tek
Instruments at (802) 655-4040 ext. 246.
